The New England Journal of Medicine,
In a 1,000-patient trial, pembrolizumab injections led to improved disease-free survival at 2 years. https://nej.md/3iQCncK
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
Overview of attention for article published in New England Journal of Medicine, August 2021
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (99th percentile)
-
Good Attention Score compared to outputs of the same age and source (79th percentile)
Mentioned by
- news
- 31 news outlets
- blogs
- 5 blogs
- policy
- 1 policy source
- 364 X users
- 1 Facebook page
- wikipedia
- 4 Wikipedia pages
- 2 Redditors
- f1000
- 1 research highlight platform
- video
- 1 YouTube creator
- guideline
- 9 clinical guideline sources
- podcasts
- 5 podcasts
Readers on
- mendeley
- 246 Mendeley